This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. (CRBP) rallied 1.71% to $9.50 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.91% to 23,817.10 and the Dow Jones Industrial Average  falling 0.83% to 49,003.41.
This was the stock's second consecutive day of gains.
Corbus Pharmaceuticals Holdings Inc. closed 53.79% below its 52-week high of $20.56, which the company achieved on October 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc. (VNDA) rose 3.08% to $8.02, Fortress Biotech Inc. (FBIO) rose 1.76% to $3.46, and Viking Therapeutics Inc. (VKTX) fell 1.04% to $31.40.
Data source: Dow Jones Market Data, FactSet. Data compiled January 27, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
01-27-26 1722ET

CRBP

SBIO

<p>Corbus Pharmaceuticals Holdings Inc. (CRBP) saw its stock rise 1.71% to $9.50 on Tuesday, marking its second consecutive day of gains. However, it remains 53.79% below its 52-week high of $20.56. In comparison, competitors Vanda Pharmaceuticals Inc. and Fortress Biotech Inc. outperformed with gains of 3.08% and 1.76%, respectively, while Viking Therapeutics Inc. experienced a decline of 1.04%. The overall market showed mixed results, with the NASDAQ up 0.91% and the Dow down 0.83%.</p>

Dow Jones

iShares Global Healthcare

iShares Biotechnology ETF

VG Health

Corbus Pharma

Invesco Biotechnology & Genome ETF

Health Care Select Sector SPDR

VanEck Biotech ETF

SPDR S&P Biotech

ALPS Medical Breakthrough

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains